The fact that AT1 is present in high-grade astrocytomas and in patients >47 years of age suggests that AT1 and AT2 could be associated with the progression of malignancy in secondary malignant astrocytomas. The gene discussed is AGTR2; the disease is astrocytoma (excluding glioblastoma).